D. S. Yakovlev

642 total citations
49 papers, 504 citations indexed

About

D. S. Yakovlev is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, D. S. Yakovlev has authored 49 papers receiving a total of 504 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Organic Chemistry, 11 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in D. S. Yakovlev's work include Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (7 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). D. S. Yakovlev is often cited by papers focused on Synthesis and biological activity (10 papers), Synthesis and Biological Evaluation (7 papers) and Neurotransmitter Receptor Influence on Behavior (4 papers). D. S. Yakovlev collaborates with scholars based in Russia, United Kingdom and Belarus. D. S. Yakovlev's co-authors include Edo S. Boek, Thomas F. Headen, А. А. Спасов, Michail A. Alterman, В. А. Анисимова, Ilya Sukhanov, Marius C. Hoener, Raul R. Gainetdinov, Stefano Espinoza and T.D. Sotnikova and has published in prestigious journals such as SHILAP Revista de lepidopterología, Langmuir and Molecules.

In The Last Decade

D. S. Yakovlev

44 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. S. Yakovlev Russia 10 188 142 137 134 133 49 504
H. Boer Netherlands 12 23 0.1× 71 0.5× 108 0.8× 56 0.4× 30 0.2× 25 421
Benjamin J. Bythell United States 10 149 0.8× 31 0.2× 57 0.4× 154 1.1× 103 0.8× 15 450
Wenxiao Wu China 11 21 0.1× 30 0.2× 29 0.2× 249 1.9× 11 0.1× 35 517
P. Bommer United States 8 53 0.3× 87 0.6× 29 0.2× 61 0.5× 10 0.1× 12 352
Xiaofeng Xie China 18 74 0.4× 24 0.2× 17 0.1× 267 2.0× 9 0.1× 56 814
Phillip Walsh United States 17 104 0.6× 62 0.4× 3 0.0× 152 1.1× 131 1.0× 29 1.0k
Heinz G. Boettger United States 12 39 0.2× 101 0.7× 4 0.0× 132 1.0× 18 0.1× 20 374
Henrik W. Anthonsen Norway 14 15 0.1× 65 0.5× 6 0.0× 216 1.6× 26 0.2× 22 495
Akwete Adjei United States 20 35 0.2× 111 0.8× 22 0.2× 167 1.2× 2 0.0× 40 1.2k
Kenji Matsubayashi Japan 13 7 0.0× 380 2.7× 13 0.1× 59 0.4× 19 0.1× 17 692

Countries citing papers authored by D. S. Yakovlev

Since Specialization
Citations

This map shows the geographic impact of D. S. Yakovlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. S. Yakovlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. S. Yakovlev more than expected).

Fields of papers citing papers by D. S. Yakovlev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. S. Yakovlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. S. Yakovlev. The network helps show where D. S. Yakovlev may publish in the future.

Co-authorship network of co-authors of D. S. Yakovlev

This figure shows the co-authorship network connecting the top 25 collaborators of D. S. Yakovlev. A scholar is included among the top collaborators of D. S. Yakovlev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. S. Yakovlev. D. S. Yakovlev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skvortsov, Dmitry A., В. А. Чертков, Борис Н. Тарасевич, et al.. (2025). Synthesis and in vitro study of a novel catechol with a hydantoin core. Medicinal Chemistry Research. 34(7). 1557–1575.
3.
Озеров, А. А., et al.. (2024). Synthesis of new heterocyclic derivatives (benzodioxane-2-yl)methanol and their effect on rat intraocular pressure. Journal of Volgograd State Medical University. 20(4). 127–135. 1 indexed citations
4.
Антоненко, Т.А., Yulia A. Gracheva, Dmitrii M. Mazur, et al.. (2024). Novel Organotin Complexes with Losartan: Synthesis and Biological Activity. Biochemistry (Moscow) Supplement Series B Biomedical Chemistry. 18(S1). S6–S17.
5.
Tyurin, V. Yu., Dmitrii M. Mazur, D. S. Yakovlev, et al.. (2024). Ruthenium complexes with abiraterone acetate as antiproliferative agents. Journal of Inorganic Biochemistry. 262. 112754–112754. 1 indexed citations
6.
Саватеев, Константин В., et al.. (2022). The Effects of Nitroazolopyrimidines on the A1 Adenosine Receptor and Intraocular Pressure in Rats. Russian Journal of Bioorganic Chemistry. 48(4). 777–782. 4 indexed citations
7.
Shpakovsky, D.B., Yulia A. Gracheva, Valentina V. Utochnikova, et al.. (2022). Cytotoxic and Luminescent Properties of Novel Organotin Complexes with Chelating Antioxidant Ligand. Molecules. 27(23). 8359–8359. 9 indexed citations
8.
Спасов, А. А., et al.. (2022). 3-ARILIDENE-2-OXYNDOLE DERIVATIVESAS MELATONIN ANALOGUES WITH ANTIOXIDANT AND INTRAOCULAR PRESSURE LOWERING PROPERTIES. Journal of Volgograd State Medical University. 19(4). 94–103. 1 indexed citations
9.
Спасов, А. А., et al.. (2022). Pharmacological Properties of 2-Aminobenzimidazole Halides and Imidazo[1,2-a]Benzimidazole Derivatives. Russian Journal of Bioorganic Chemistry. 48(2). 281–291. 3 indexed citations
10.
Спасов, А. А., et al.. (2021). Searching for new anxiolytic agents among derivatives of 11-dialkylaminoethyl-2,3,4,5-tetrahydrodiazepino[1,2-a]benzimidazole. European Journal of Pharmaceutical Sciences. 161. 105792–105792. 8 indexed citations
11.
Yakovlev, D. S., et al.. (2020). CUMULATIVE PROPERTIES OF THE NEW ANTI-MIGENOUS COMPOUND IN THE TABLET MEDICAL FORM. Journal of Volgograd State Medical University. 17(4). 46–49.
12.
Спасов, А. А., et al.. (2019). Novel Approaches to the Development of Antimigraine Drugs: A Focus on 5-HT2A Receptor Antagonists. Russian Journal of Bioorganic Chemistry. 45(2). 76–88. 3 indexed citations
13.
Yakovlev, D. S., et al.. (2019). Neuroprotective effects of taurine and 3-hydroxypyridine derivatives in the intracerebral hemorrhage model in rats. SHILAP Revista de lepidopterología. 5(3). 87–94. 5 indexed citations
14.
Yakovlev, D. S., et al.. (2018). ANALYTICAL PROPERTIES OF COMPOUND RU-31. Journal of Volgograd State Medical University. 15(3). 28–32. 6 indexed citations
15.
Спасов, А. А., et al.. (2014). In Vitro Method of Studying the Angiotensin Activity of Chemical Compounds. Bulletin of Experimental Biology and Medicine. 158(1). 115–117. 7 indexed citations
16.
Sukhanov, Ilya, Stefano Espinoza, D. S. Yakovlev, et al.. (2014). TAAR1-dependent effects of apomorphine in mice. The International Journal of Neuropsychopharmacology. 17(10). 1683–1693. 36 indexed citations
17.
Yakovlev, D. S., et al.. (2014). Effect of 5-HT2A Receptor Antagonists on Blood Flow in the Carotid Vessels upon Elevation of Serotonin Level. Bulletin of Experimental Biology and Medicine. 157(3). 350–352. 7 indexed citations
18.
Спасов, А. А., et al.. (2013). Synthesis and pharmacological activity of amides of 2-amino-3-indolylacrylic acid. Pharmaceutical Chemistry Journal. 46(10). 584–590. 3 indexed citations
19.
Yakovlev, D. S., et al.. (2012). Systematic Optimization of Asphaltene Molecular Structure and Molecular Weight Using the Quantitative Molecular Representation Approach. Energy & Fuels. 26(10). 6177–6185. 21 indexed citations
20.
Alterman, Michail A., et al.. (2005). QUANTITATIVE ANALYSIS OF CYTOCHROME P450 ISOZYMES BY MEANS OF UNIQUE ISOZYME-SPECIFIC TRYPTIC PEPTIDES: A PROTEOMIC APPROACH. Drug Metabolism and Disposition. 33(9). 1399–1407. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026